The global epidural anesthetic drugs market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of surgeries and rising demand for minimally invasive procedures. The North American region is expected to dominate the global epidural anesthetic drugs market in terms of revenue, followed by Europe and Asia Pacific.
Some Of The Growth Factors Of This Market:
- Increasing number of surgeries and rising healthcare expenditure are the major factors driving the growth of this market.
- Increasing prevalence of chronic pain and increasing geriatric population are also driving the growth of this market.
- The global Epidural Anesthetic Drugs market is highly competitive with many players operating in it.
- The key players in this industry include Hospira, Inc, B Braun Melsungen AG, Abbott Laboratories, AstraZeneca plc., Baxter International Inc, Pfizer Inc, and others.
Industry Growth Insights published a new data on “Epidural Anesthetic Drugs Market”. The research report is titled “Epidural Anesthetic Drugs Market research by Types (Bupivacaine, Chloroprocaine, Lidocaine, Others, ), By Applications (Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures, Others, ), By Players/Companies Taj Pharmaceuticals Ltd, Pfizer, Fresenius Kabi, Areva Pharmaceuticals Inc., Farco Pharma GmbH, Mahendra Chemicals, Aurobindo Pharma Ltd, Amphastar Pharmaceuticals, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Epidural Anesthetic Drugs Market Research Report
By Type
Bupivacaine, Chloroprocaine, Lidocaine, Others,
By Application
Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures, Others,
By Companies
Taj Pharmaceuticals Ltd, Pfizer, Fresenius Kabi, Areva Pharmaceuticals Inc., Farco Pharma GmbH, Mahendra Chemicals, Aurobindo Pharma Ltd, Amphastar Pharmaceuticals, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Epidural Anesthetic Drugs Market Report Segments:
The global Epidural Anesthetic Drugs market is segmented on the basis of:
Types
Bupivacaine, Chloroprocaine, Lidocaine, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Taj Pharmaceuticals Ltd
- Pfizer
- Fresenius Kabi
- Areva Pharmaceuticals Inc.
- Farco Pharma GmbH
- Mahendra Chemicals
- Aurobindo Pharma Ltd
- Amphastar Pharmaceuticals, Inc.
Highlights of The Epidural Anesthetic Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bupivacaine
- Chloroprocaine
- Lidocaine
- Others
- By Application:
- Abdomen Procedures
- Pelvic Procedures
- Lower Extremity Procedures
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epidural Anesthetic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epidural anesthetics are drugs that block nerve impulses from traveling to the brain. This can cause pain relief and relaxation.
Some of the major players in the epidural anesthetic drugs market are Taj Pharmaceuticals Ltd, Pfizer, Fresenius Kabi, Areva Pharmaceuticals Inc., Farco Pharma GmbH, Mahendra Chemicals, Aurobindo Pharma Ltd, Amphastar Pharmaceuticals, Inc..
The epidural anesthetic drugs market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Epidural Anesthetic Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Epidural Anesthetic Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Epidural Anesthetic Drugs Market - Supply Chain
4.5. Global Epidural Anesthetic Drugs Market Forecast
4.5.1. Epidural Anesthetic Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Epidural Anesthetic Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Epidural Anesthetic Drugs Market Absolute $ Opportunity
5. Global Epidural Anesthetic Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Epidural Anesthetic Drugs Market Size and Volume Forecast by Type
5.3.1. Bupivacaine
5.3.2. Chloroprocaine
5.3.3. Lidocaine
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Epidural Anesthetic Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Epidural Anesthetic Drugs Market Size and Volume Forecast by Application
6.3.1. Abdomen Procedures
6.3.2. Pelvic Procedures
6.3.3. Lower Extremity Procedures
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Epidural Anesthetic Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Epidural Anesthetic Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Epidural Anesthetic Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Epidural Anesthetic Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Epidural Anesthetic Drugs Demand Share Forecast, 2019-2026
9. North America Epidural Anesthetic Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Epidural Anesthetic Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Epidural Anesthetic Drugs Market Size and Volume Forecast by Application
9.4.1. Abdomen Procedures
9.4.2. Pelvic Procedures
9.4.3. Lower Extremity Procedures
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Epidural Anesthetic Drugs Market Size and Volume Forecast by Type
9.7.1. Bupivacaine
9.7.2. Chloroprocaine
9.7.3. Lidocaine
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Epidural Anesthetic Drugs Demand Share Forecast, 2019-2026
10. Latin America Epidural Anesthetic Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Epidural Anesthetic Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Epidural Anesthetic Drugs Market Size and Volume Forecast by Application
10.4.1. Abdomen Procedures
10.4.2. Pelvic Procedures
10.4.3. Lower Extremity Procedures
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Epidural Anesthetic Drugs Market Size and Volume Forecast by Type
10.7.1. Bupivacaine
10.7.2. Chloroprocaine
10.7.3. Lidocaine
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Epidural Anesthetic Drugs Demand Share Forecast, 2019-2026
11. Europe Epidural Anesthetic Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Epidural Anesthetic Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Epidural Anesthetic Drugs Market Size and Volume Forecast by Application
11.4.1. Abdomen Procedures
11.4.2. Pelvic Procedures
11.4.3. Lower Extremity Procedures
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Epidural Anesthetic Drugs Market Size and Volume Forecast by Type
11.7.1. Bupivacaine
11.7.2. Chloroprocaine
11.7.3. Lidocaine
11.7.4. Others
1.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Epidural Anesthetic Drugs Demand Share, 2019-2026
12. Asia Pacific Epidural Anesthetic Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Epidural Anesthetic Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Epidural Anesthetic Drugs Market Size and Volume Forecast by Application
12.4.1. Abdomen Procedures
12.4.2. Pelvic Procedures
12.4.3. Lower Extremity Procedures
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Epidural Anesthetic Drugs Market Size and Volume Forecast by Type
12.7.1. Bupivacaine
12.7.2. Chloroprocaine
12.7.3. Lidocaine
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Epidural Anesthetic Drugs Demand Share, 2019-2026
13. Middle East & Africa Epidural Anesthetic Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Epidural Anesthetic Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Epidural Anesthetic Drugs Market Size and Volume Forecast by Application
13.4.1. Abdomen Procedures
13.4.2. Pelvic Procedures
13.4.3. Lower Extremity Procedures
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Epidural Anesthetic Drugs Market Size and Volume Forecast by Type
13.7.1. Bupivacaine
13.7.2. Chloroprocaine
13.7.3. Lidocaine
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Epidural Anesthetic Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Epidural Anesthetic Drugs Market: Market Share Analysis
14.2. Epidural Anesthetic Drugs Distributors and Customers
14.3. Epidural Anesthetic Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Taj Pharmaceuticals Ltd
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fresenius Kabi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Areva Pharmaceuticals Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Farco Pharma GmbH
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mahendra Chemicals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aurobindo Pharma Ltd
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Amphastar Pharmaceuticals, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
